These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37062887)

  • 1. Using social media listening to understand barriers to genomic medicine for those living with Ehlers-Danlos syndromes and hypermobility spectrum disorders.
    Kline E; Garrett AL; Brownstein C; Ziniel S; Payton E; Goldin A; Hoffman K; Chandler J; Weber S
    Health Expect; 2023 Aug; 26(4):1524-1535. PubMed ID: 37062887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient experience of chronic illness care and complementary integrative health use: a cross-sectional study of patients with hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndromes (EDS).
    Guedry SE; Langley BO; Schaefer K; Hanes DA
    Disabil Rehabil; 2023 Oct; 45(21):3549-3559. PubMed ID: 36222285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.
    Micale L; Fusco C; Castori M
    Adv Exp Med Biol; 2021; 1348():207-233. PubMed ID: 34807421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rate of dyspareunia and probable vulvodynia in Ehlers-Danlos syndromes and hypermobility spectrum disorders: An online survey.
    Glayzer JE; McFarlin BL; Castori M; Suarez ML; Meinel MC; Kobak WH; Steffen AD; Schlaeger JM
    Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):599-608. PubMed ID: 34747110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative medicine for hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndromes (EDS): a feasibility study.
    Guedry SE; Langley BO; Schaefer K; Hanes DA
    Disabil Rehabil; 2024 Feb; ():1-14. PubMed ID: 38353245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Diversity in Research on Females with Ehlers-Danlos Syndromes: Recruitment Protocol for a Quantitative Online Survey.
    Glayzer JE; Bray BC; Kobak WH; Steffen AD; Schlaeger JM
    JMIR Res Protoc; 2024 May; 13():e53646. PubMed ID: 38696252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial description and evaluation of EDS ECHO: An international effort to improve care for people with the Ehlers-Danlos syndromes and hypermobility spectrum disorders.
    Schubart JR; Bascom R; Francomano CA; Bloom L; Hakim AJ
    Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):609-615. PubMed ID: 34821464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of video-based joint hypermobility assessment in individuals with suspected Ehlers-Danlos syndromes/generalised hypermobility spectrum disorders: a single-site observational study protocol.
    Mittal N; Sabo A; Deshpande A; Clarke H; Taati B
    BMJ Open; 2022 Dec; 12(12):e068098. PubMed ID: 36526308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ehlers-Danlos syndrome, hypermobility type: A characterization of the patients' lived experience.
    Murray B; Yashar BM; Uhlmann WR; Clauw DJ; Petty EM
    Am J Med Genet A; 2013 Dec; 161A(12):2981-8. PubMed ID: 24254846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urogenital and pelvic complications in the Ehlers-Danlos syndromes and associated hypermobility spectrum disorders: A scoping review.
    Gilliam E; Hoffman JD; Yeh G
    Clin Genet; 2020 Jan; 97(1):168-178. PubMed ID: 31420870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entrapment neuropathies and polyneuropathies in joint hypermobility syndrome/Ehlers-Danlos syndrome.
    Granata G; Padua L; Celletti C; Castori M; Saraceni VM; Camerota F
    Clin Neurophysiol; 2013 Aug; 124(8):1689-94. PubMed ID: 23743406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Hypermobile "Ehlers-Danlos Syndrome" and Hypermobile Spectrum Disorder on Interpersonal Interactions and Relationships.
    De Baets S; De Temmerman M; Calders P; Malfait F; Van Hove G; Vanderstraeten G; De Wandele I; Van de Velde D
    Front Rehabil Sci; 2022; 3():832806. PubMed ID: 36188999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorders in the context of childbearing: An international qualitative study.
    Pezaro DS; Pearce DG; Reinhold DE
    Midwifery; 2020 Sep; 88():102749. PubMed ID: 32535291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of complementary therapies for chronic pain management in patients with reported Ehlers-Danlos syndrome or hypermobility spectrum disorders.
    Demes JS; McNair B; Taylor MRG
    Am J Med Genet A; 2020 Nov; 182(11):2611-2623. PubMed ID: 32909698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
    Bennett SE; Walsh N; Moss T; Palmer S
    Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case-control comparison.
    Demmler JC; Atkinson MD; Reinhold EJ; Choy E; Lyons RA; Brophy ST
    BMJ Open; 2019 Nov; 9(11):e031365. PubMed ID: 31685485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.
    Chohan K; Mittal N; McGillis L; Lopez-Hernandez L; Camacho E; Rachinsky M; Mina DS; Reid WD; Ryan CM; Champagne KA; Orchanian-Cheff A; Clarke H; Rozenberg D
    Chron Respir Dis; 2021; 18():14799731211025313. PubMed ID: 34291699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise beliefs and behaviours of individuals with Joint Hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type.
    Simmonds JV; Herbland A; Hakim A; Ninis N; Lever W; Aziz Q; Cairns M
    Disabil Rehabil; 2019 Feb; 41(4):445-455. PubMed ID: 29125009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
    Yew KS; Kamps-Schmitt KA; Borge R
    Am Fam Physician; 2021 Apr; 103(8):481-492. PubMed ID: 33856167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.